4.6 Article

Association of plasma soluble E-selectin and adiponectin with carotid plaque in patients with systemic lupus erythematosus

Journal

ATHEROSCLEROSIS
Volume 210, Issue 2, Pages 569-574

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.atherosclerosis.2009.12.007

Keywords

Systemic lupus erythematosus; Atherosclerosis; Carotid stenosis; Adiponectin; E-selectin

Funding

  1. Lupus Research Institute, New York, NY
  2. NIH/NCRR [M01 RR0096]
  3. SLE Foundation, Inc.
  4. Arthritis Foundation, New York

Ask authors/readers for more resources

Background: Systemic lupus erythematosus (SLE) is associated with premature atherosclerosis but the mechanisms underlying this association are not understood. The role of endothelial dysfunction is hypothesized. Methods: In predominantly non-Caucasian patients with SLE (N = 119) and controls (N = 71), carotid ultrasonography was performed and circulating endothelial cells (CECs), soluble endothelial protein C receptor and gene polymorphism at A6936G, soluble E-selectin (sE-selectin), and adiponectin were assessed. Results: Carotid plaque was more prevalent among patients than controls (43% vs 17%, p = 0.0002). Mean CCA IMT was greater in patients compared to controls (0.59 +/- 0.19 mm vs 0.54 +/- 0.11 mm, p = 0.03). Among SLE patients, plaque was not associated with smoking, body-mass index, LDL, triglycerides, homocysteine, C-reactive protein, anti-ds DNA antibody, C3, C4, SLE activity, or medications. Age and levels of soluble E-selectin and adiponectin were significantly higher in the SLE patients with plaque compared to those without plaque in univariate and multivariate analyses. sE-selectin and adiponectin were found to serve as independent predictors of carotid plaque and that elevations were persistent over more than one visit. Unexpectedly, these biomarkers were present despite clinical quiescence. Conclusion: Premature atherosclerosis is a consistent feature of SLE and extends across ethnicities. Higher levels of adiponectin may represent a physiological attempt to limit further endothelial damage already reflected by the elevation in sE-selectin and the observed increase in plaque represents overwhelming of this reparative process by atherogenic stimuli. (C) 2009 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in Women

Harmony R. Reynolds, Akiko Maehara, Raymond Y. Kwong, Tara Sedlak, Jacqueline Saw, Nathaniel R. Smilowitz, Ehtisham Mahmud, Janet Wei, Kevin Marzo, Mitsuaki Matsumura, Ayako Seno, Anais Hausvater, Caitlin Giesler, Nisha Jhalani, Catalin Toma, Bryan Har, Dwithiya Thomas, Laxmi S. Mehta, Jeffrey Trost, Puja K. Mehta, Bina Ahmed, Kevin R. Bainey, Yuhe Xia, Binita Shah, Michael Attubato, Sripal Bangalore, Louai Razzouk, Ziad A. Ali, Noel Bairey Merz, Ki Park, Ellen Hada, Hua Zhong, Judith S. Hochman

Summary: Multimodality imaging with coronary OCT and CMR identified potential mechanisms in 84.5% of women with a diagnosis of MINOCA, 75.5% of which were ischemic and 24.5% of which were nonischemic, providing valuable guidance for medical therapy in secondary prevention.

CIRCULATION (2021)

Article Rheumatology

Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS-CoV-2 Vaccination

Peter M. Izmirly, Mimi Y. Kim, Marie Samanovic, Ruth Fernandez-Ruiz, Sharon Ohana, Kristina K. Deonaraine, Alexis J. Engel, Mala Masson, Xianhong Xie, Amber R. Cornelius, Ramin S. Herati, Rebecca H. Haberman, Jose U. Scher, Allison Guttmann, Rebecca B. Blank, Benjamin Plotz, Mayce Haj-Ali, Brittany Banbury, Sara Stream, Ghadeer Hasan, Gary Ho, Paula Rackoff, Ashira D. Blazer, Chung-E Tseng, H. Michael Belmont, Amit Saxena, Mark J. Mulligan, Robert M. Clancy, Jill P. Buyon

Summary: In a multiethnic/multiracial study of SLE patients, 29% had a low response to the COVID-19 vaccine which was associated with receiving immunosuppressive therapy. Severe disease flares were rare.

ARTHRITIS & RHEUMATOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Coronary Arterial Function and Disease in Women With No Obstructive Coronary Arteries

Harmony R. Reynolds, C. Noel Bairey Merz, Colin Berry, Rohit Samuel, Jacqueline Saw, Nathaniel R. Smilowitz, Ana Carolina do A. H. de Souza, Robert Sykes, Viviany R. Taqueti, Janet Wei

Summary: Ischemic heart disease is the leading cause of mortality in women and requires gender-specific risk stratification for prevention, diagnosis, and treatment. Recent research has improved understanding of cardiovascular disease in women, including mechanisms of ischemia with no obstructive coronary arteries and myocardial infarction with no obstructive coronary arteries. Despite progress, sex differences in ischemic heart disease outcomes persist.

CIRCULATION RESEARCH (2022)

Article Rheumatology

Urine Proteomics and Renal Single-Cell Transcriptomics Implicate Interleukin-16 in Lupus Nephritis

Andrea Fava, Deepak A. Rao, Chandra Mohan, Ting Zhang, Avi Rosenberg, Paride Fenaroli, H. Michael Belmont, Peter Izmirly, Robert Clancy, Jose Monroy Trujillo, Derek Fine, Arnon Arazi, Celine C. Berthier, Anne Davidson, Judith A. James, Betty Diamond, Nir Hacohen, David Wofsy, Soumya Raychaudhuri, William Apruzzese, Jill Buyon, Michelle Petri

Summary: By analyzing longitudinal urinary proteomic profiles in patients with Lupus Nephritis (LN), this study identified multiple biologic pathways and 237 urinary biomarkers associated with LN. IL-16 was identified as a key factor in LN pathogenesis and a potential target for treatment and biomarker.

ARTHRITIS & RHEUMATOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Outcomes With Intermediate Left Main Disease: Analysis From the ISCHEMIA Trial

Sripal Bangalore, John A. Spertus, Susanna R. Stevens, Philip G. Jones, G. B. John Mancini, Jonathon Leipsic, Harmony R. Reynolds, Matthew J. Budoff, Cameron J. Hague, James K. Min, William E. Boden, Sean M. O'Brien, Robert A. Harrington, Jeffrey S. Berger, Roxy Senior, Jesus Peteiro, Neeraj Pandit, Leonid Bershtein, Mark A. de Belder, Hanna Szwed, Rolf Doerr, Lorenzo Monti, Khaled Alfakih, Judith S. Hochman, David J. Maron

Summary: The study found that intermediate left main disease (LMD) was associated with cardiovascular events. An invasive strategy can reduce nonprocedural MI and improve angina-related quality of life.

CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2022)

Article Health Care Sciences & Services

Cardiovascular Disease Prevention Education Using a Virtual Environment in Sexual-Minority Men of Color With HIV: Protocol for a Sequential, Mixed Method, Waitlist Randomized Controlled Trial

S. Raquel Ramos, Constance Johnson, Gail Melkus, Trace Kershaw, Marya Gwadz, Harmony Reynolds, Allison Vorderstrasse

Summary: This study proposes the first technology-based virtual environment intervention for addressing behavioral risk factors associated with cardiovascular and metabolic comorbidities in sexual-minority men of color with HIV. The study has been approved by institutional review boards and data collection is ongoing, with expectations of positive outcomes for CVD prevention education and peer social support.

JMIR RESEARCH PROTOCOLS (2022)

Letter Cardiac & Cardiovascular Systems

To Be or Not to Be Treated: That Is the Question in Managing a Fetus With Cardiac Injury Exposed to Anti-SSA/Ro

Jill Buyon, Amit Saxena, Deborah Friedman, Peter Izmirly

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Article Cardiac & Cardiovascular Systems

Survival After Invasive or Conservative Management of Stable Coronary Disease

Judith S. Hochman, Rebecca Anthopolos, Harmony. R. Reynolds, Sripal Bangalore, Yifan Xu, Sean M. O'Brien, Stavroula Mavromichalis, Michelle Chang, Aira Contreras, Yves Rosenberg, Ruth Kirby, Balram Bhargava, Roxy Senior, Ann Banfield, Shaun G. Goodman, Renato D. Lopes, Radoslaw Pracon, Jose Lopez-Sendon, Aldo Pietro Maggioni, Jonathan D. Newman, Jeffrey S. Berger, Mandeep S. Sidhu, Harvey D. White, Andrea B. Troxel, Robert A. Harrington, William E. Boden, Gregg W. Stone, Daniel B. Mark, John A. Spertus, David J. Maron

Summary: The ISCHEMIA trial compared the outcomes of initial invasive strategy versus initial conservative strategy in patients with chronic coronary disease and moderate or severe ischemia. The trial found no major difference in most outcomes, but there was lower risk of cardiovascular mortality and higher risk of noncardiovascular mortality with the invasive strategy.

CIRCULATION (2023)

Article Rheumatology

Population-based prevalence and incidence estimates of mixed connective tissue disease from the Manhattan Lupus Surveillance Program

Ghadeer Hasan, Elizabeth D. Ferucci, Jill P. Buyon, H. Michael Belmont, Jane E. Salmon, Anca Askanase, Joan M. Bathon, Laura Geraldino-Pardilla, Yousaf Ali, Ellen M. Ginzler, Chaim Putterman, Caroline Gordon, Charles G. Helmick, Hilary Parton, Peter M. Izmirly

Summary: Using data from the MLSP, we estimated the prevalence and incidence of MCTD. The variation in estimates using different case definitions highlights the challenges in defining MCTD in epidemiological studies.

RHEUMATOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Repetitive catamenial myocardial infarction due to coronary artery spasm: a case report

Nina Talmor, Michael Gurin, Nathaniel Smilowitz, Dana Gossett, Bruria Eisner, Mitchell Pleasure, Harmony R. Reynolds

Summary: This case report describes a 37-year-old woman with recurrent non-ST elevation myocardial infarction (NSTEMI) during her menstrual periods. Intracoronary acetylcholine provocation testing revealed coronary spasm in the left anterior descending artery (LAD) that was relieved with nitroglycerine. Initiating calcium channel blockade and suppressing cyclical variation in sex hormones improved her symptoms and prevented monthly NSTEMI events caused by coronary spasm.

EUROPEAN HEART JOURNAL-CASE REPORTS (2023)

Article Cardiac & Cardiovascular Systems

Cancer and Myocardial Infarction in Women

Priya Panday, Anais Hausvater, Mitchell Pleasure, Nathaniel R. Smilowitz, Harmony R. Reynolds

Summary: Women with myocardial infarction (MI) are more likely to have nonobstructive coronary artery disease (MINOCA), spontaneous coronary artery dissection (SCAD), and takotsubo syndrome (TS) than men. This study aims to determine the prevalence of cancer in women with MI and investigate its association with the mechanism of MI presentation.

AMERICAN JOURNAL OF CARDIOLOGY (2023)

Article Rheumatology

Longitudinal gut microbiome analyses and blooms of pathogenic strains during lupus disease flares

Doua Azzouz, Ze Chen, Peter M. Izmirly, Lea Ann Chen, Zhi Li, Chongda Zhang, David Mieles, Kate Trujillo, Adriana Heguy, Alejandro Pironti, Greg G. Putzel, Dominik Schwudke, David Fenyo, Jill P. Buyon, Alexander Alekseyenko, Nicolas Gisch, Gregg J. Silverman

Summary: This study investigated the relationship between gut microbiota and disease activity in systemic lupus erythematosus (SLE) patients. The results showed that SLE patients had unstable microbiota communities and experienced intestinal growth spikes of pathogenic species during disease flares. The expansion of Ruminococcus (blautia) gnavus (RG) was associated with high-disease activity and lupus nephritis (LN) flares, and specific RG strains isolated during flares expressed a novel type of cell membrane-associated lipoglycan.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Cardiac & Cardiovascular Systems

Effect of the P-Selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial

Scott D. J. Solomon, Charles J. S. Lowenstein, Ankeet S. Bhatt, Alexander Peikert, Orly N. Vardeny, Mikhail N. S. Kosiborod, Jeffrey S. R. Berger, Harmony R. Reynolds, Stephanie Mavromichalis, Anya D. Barytol, Andrew D. F. Althouse, James F. S. Luther, Eric S. L. Leifer, Andrei L. Kindzelski, Mary N. Cushman, Michelle N. Z. Gong, Lucy Z. Kornblith, Pooja S. Khatri, Keri S. Kim, Lisa Baumann Kreuziger, Lana Wahid, Bridget-Anne W. Kirwan, Mark W. D. Geraci, Matthew D. S. Neal, Judith S. Hochman

Summary: This study aimed to evaluate the efficacy of using the P-selectin inhibitor crizanlizumab in reducing mortality and disease progression in COVID-19 patients. However, the results showed that the drug did not improve organ support-free days in patients hospitalized with COVID-19.

CIRCULATION (2023)

Editorial Material Cardiac & Cardiovascular Systems

Chronic Coronary Disease Guidelines

Sunil V. Rao, Harmony R. Reynolds, Judith S. Hochman

CIRCULATION (2023)

No Data Available